Front Aging News Today

Available evidence from preclinical studies indicates that semaglutide shows promise for treating Alzheimer disease and Parkinson disease.

The safety and efficacy of long-term benzodiazepine use beyond the recommended timeframe is not well understood.

Death has always been a mystery to human beings. What can people see or feel when they are ...